Lv5
1490 积分 2023-09-01 加入
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
26天前
已关闭
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
27天前
已完结
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
27天前
已完结
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
27天前
已完结
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial
1个月前
已完结
Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial
1个月前
已完结
Symposium Summary: "Breathe In, Breathe Out, Its Easy: What You Need to Know About Developing Inhaled Drugs"
1个月前
已完结
Toxicologic Testing of Inhaled Pharmaceutical Aerosols
1个月前
已完结
Association of Inhalation Toxicologists (AIT) Working Party Recommendation for Standard Delivered Dose Calculation and Expression in Non-Clinical Aerosol Inhalation Toxicology Studies with Pharmaceuticals
1个月前
已完结
Population Modeling of Selexipag Pharmacokinetics and Clinical Response Parameters in Patients With Pulmonary Arterial Hypertension
2个月前
已完结
皖公网安备34019202002308
